Latest News
Featured News
Director Dealing
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Modi-1 Phase 1/2 clinical trial open for recruitment
Broadening of COVIDITY Phase 1 clinical trial in South Africa
Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™
Update on COVIDITY Phase 1 clinical trial in South Africa
Interim Results for the 6 months ended 31 October 2021
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.